{
  "society": "ALEH",
  "version": "2024",
  "publication_date": "2024-08-01",
  "title": "ALEH (Latin American) MASLD position",
  "status": "published",
  "recommendations": [
    {"recommendation_id": "ALEH-2024-R01", "topic": "definition", "text_en": "ALEH adopts MASLD nomenclature; emphasizes Latin American obesity epidemiology.", "text_kr_summary": "ALEH MASLD 채택; 남미 비만 역학.", "strength": "strong", "evidence_grade": "B", "cite_pmids": ["37363821"], "related_nits": [], "related_drugs": []},
    {"recommendation_id": "ALEH-2024-R02", "topic": "screening", "text_en": "T2DM and MetS screened with FIB-4 then ELF or VCTE.", "text_kr_summary": "T2DM/MetS FIB-4 -> ELF/VCTE.", "strength": "strong", "evidence_grade": "B", "cite_pmids": ["33271056"], "related_nits": ["FIB-4", "ELF", "LSM"], "related_drugs": []},
    {"recommendation_id": "ALEH-2024-R03", "topic": "fib4_cutoff", "text_en": "FIB-4 1.3/2.67 cutoffs Latin American validation.", "text_kr_summary": "FIB-4 남미 검증.", "strength": "strong", "evidence_grade": "B", "cite_pmids": ["17326139"], "related_nits": ["FIB-4"], "related_drugs": []},
    {"recommendation_id": "ALEH-2024-R04", "topic": "weight_loss", "text_en": "Weight loss target 7-10%; Mediterranean-Latino dietary patterns.", "text_kr_summary": "7-10% 감량.", "strength": "strong", "evidence_grade": "A", "cite_pmids": ["25865049"], "related_nits": [], "related_drugs": []},
    {"recommendation_id": "ALEH-2024-R05", "topic": "resmetirom", "text_en": "Resmetirom: regional regulators evaluating; access through compassionate use channels.", "text_kr_summary": "지역 규제 평가; 인도주의 사용.", "strength": "weak", "evidence_grade": "C", "cite_pmids": ["38324483"], "related_nits": [], "related_drugs": ["resmetirom"]}
  ]
}